A Dose-Selection Study of Clobetasol Propionate Ophthalmic Suspension that Evaluated Inflammation and Pain after Cataract Surgery
CPN 0.05% administered twice a day has the potential to be a safe and effective treatment for inflammation after cataract surgery.
Authors
- Thomas R. Walters (ORCID: https://orcid.org/0000-0001-9208-6734)
- Jeffrey Levenson (ORCID: https://orcid.org/0000-0001-7454-8755)
- Derek J. Nunez (ORCID: https://orcid.org/0000-0003-4704-3967)
- L Wang
- Joseph Martel
Institutions
- Martel (CH)
- Eye Care Associates (US)
- Casma Therapeutics (United States) (US)
- Keystone College (US)
Publication Details
- Journal
- Journal of Cataract & Refractive Surgery
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1097/j.jcrs.0000000000001845
- Primary Topic
- Ocular Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00